Literature DB >> 22490919

[Signal transduction pathways mediated by Toll-like receptors and their relations with fungal keratitis].

Peng Chen1, Li-xin Xie.   

Abstract

Toll-like receptors (TLRs) were identified as transmembrane signal transduction proteins in recent years. As a group of pattern recognition receptors (PRRs), TLRs play important roles in the innate immunity by recognizing pathogen-associated molecular patterns (PAMPs). Activated innate immunity subsequently leads to effective adaptive immunity. It, thereby, activities not only innate but ultimately also adaptive immunity. It has been reported that some kinds of TLRs expressed in corneal epithelial cells, stroma cells and endothelial cells. In addition to their recognition function, TLR activation triggers a complex signal transduction cascade that induces the production of inflammatory cytokines and co-stimulatory molecules, thus initiating innate and adaptive immunity. And TLRs play an important role in innate and adaptive immunity of fungal keratitis. In summary, further studies on the regulation of intracellular signaling transduction will contribute significantly to our understanding of immunoregulation of fungal keratitis, eventually provide some way to cure the fungal infection.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22490919

Source DB:  PubMed          Journal:  Zhonghua Yan Ke Za Zhi        ISSN: 0412-4081


  2 in total

1.  High-mobility group box1 as an amplifier of immune response and target for treatment in Aspergillus fumigatus keratitis.

Authors:  Meng-Qi Wu; Cui Li; Li-Na Zhang; Jing Lin; Kun He; Ya-Wen Niu; Cheng-Ye Che; Nan Jiang; Jia-Qian Jiang; Gui-Qiu Zhao
Journal:  Int J Ophthalmol       Date:  2020-05-18       Impact factor: 1.779

2.  Expression of vitamin D receptor and cathelicidin in human corneal epithelium cells during fusarium solani infection.

Authors:  Lin Cong; Yi-Ping Xia; Gui-Qiu Zhao; Jing Lin; Qiang Xu; Li-Ting Hu; Jian-Qiu Qu; Xu-Dong Peng
Journal:  Int J Ophthalmol       Date:  2015-10-18       Impact factor: 1.779

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.